Skip to main content
AI Market Summary
Loading market intelligence...

Midland States Bancorp, Inc. (MSBI) Stock Forecast 2025 - AI Price Prediction & Analysis


Midland States Bancorp, Inc. (MSBI) AI Stock Price Forecast & Investment Analysis

Midland States Bancorp, Inc. Stock Price Chart and Technical Analysis

Loading Midland States Bancorp, Inc. interactive price chart and technical analysis...

Midland States Bancorp, Inc. (MSBI) - Comprehensive Stock Analysis & Investment Research

Deep dive into Midland States Bancorp, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Midland States Bancorp, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Midland States Bancorp, Inc.: Midland States Bancorp, Inc. operates in the Finance sector, making it an emerging small-cap investment.

Midland States Bancorp, Inc. (Stock Symbol: MSBI) is a leading company in the Finance sector , specifically operating within the State Commercial Banks industry.

The organization employs approximately 729 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Midland States Bancorp, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Midland States Bancorp, Inc.: With $253M in annual revenue and 28.5% net margin, the company demonstrates exceptional profitability.

Annual Revenue: $253 million generating a 28.5% net profit margin .

Market Capitalization: $459 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): 12.9% - Above-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Midland States Bancorp, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Midland States Bancorp, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Midland States Bancorp, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Midland States Bancorp, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Midland States Bancorp, Inc.: Strong free cash flow generation demonstrates solid operational efficiency.

Midland States Bancorp, Inc. strategically competes in the highly dynamic State Commercial Banks marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company demonstrates robust operational efficiency through strong free cash flow generation of $213 million annually, complemented by impressive 318.0% year-over-year cash flow growth.

Midland States Bancorp, Inc. (MSBI) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Midland States Bancorp, Inc. stock analysis.

Loading Midland States Bancorp, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into Midland States Bancorp, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Midland States Bancorp, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Midland States Bancorp, Inc.: With a P/E ratio of 7.41, the market sees the stock as potentially undervalued.

P/E Ratio 7.41x
P/B Ratio 0.79x
Market Cap $459M
Dividend Yield 6.00%
EPS $2.01
Book Value/Share $27.12
Revenue/Share $11.66
FCF/Share $3.17
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Midland States Bancorp, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Midland States Bancorp, Inc.: An ROE of 12.9% shows good shareholder value creation.

ROE 12.9%
ROA 1.2%
Net Margin 28.5%
EBT Margin 35.3%
Tax Rate 18.5%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Midland States Bancorp, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Midland States Bancorp, Inc.:

D/E Ratio 0.71x
Financial Leverage 11.38x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Midland States Bancorp, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Midland States Bancorp, Inc.: Free cash flow of $213M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $215M
Free Cash Flow $213M
Capital Spending $-3M
OCF Growth YoY 318.0%
FCF Growth YoY 336.1%
FCF/Sales 73.3%
CapEx/Sales 0.9%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Midland States Bancorp, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Midland States Bancorp, Inc.: An asset turnover of 0.04x suggests room for improvement in asset utilization.

Asset Turnover 0.04x
Fixed Assets Turnover 3.6x
Understanding Financial Statement Data

What these metrics mean: Key figures from Midland States Bancorp, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Midland States Bancorp, Inc.: With annual revenue of $253M, Midland States Bancorp, Inc. demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $253M
SG&A Expense $41M
Balance Sheet Highlights (% Of Assets)
Cash & Short-term Investments 16%
Total Liabilities 91%
Short-term Debt 0%
Accounts Receivable 6%
Dividend & Shareholder Information
Dividends Per Share $1.23
Payout Ratio 1.3%
Shares Outstanding 22M
Growth Metrics (YoY)
EPS Growth 10.4%

Latest Midland States Bancorp, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Midland States Bancorp, Inc. (MSBI) stock price and investment outlook.

Midland States Bancorp, Inc. Competitors & Peer Analysis - Finance Sector

Comparative analysis of Midland States Bancorp, Inc. against industry peers and competitors in the Finance sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ABCB Unlock Forecast - 30 Days FREE Trial $5365M 13.5x 1.3x
ACNB Unlock Forecast - 30 Days FREE Trial $542M 16.5x 1.3x
AMAL Unlock Forecast - 30 Days FREE Trial $963M 9.4x 1.4x
ASB Unlock Forecast - 30 Days FREE Trial $4496M 25.5x 0.9x
ASBA Unlock Forecast - 30 Days FREE Trial $4121M 23.4x 0.9x
ASB-PE Unlock Forecast - 30 Days FREE Trial $3572M 20.3x 0.7x
ASB-PF Unlock Forecast - 30 Days FREE Trial $3447M 19.6x 0.7x
AUB Unlock Forecast - 30 Days FREE Trial $5194M 23.7x 1.1x
AUBN Unlock Forecast - 30 Days FREE Trial $87M 12.1x 1.1x
AUB-PA Unlock Forecast - 30 Days FREE Trial $3508M 16.0x 0.7x
BAFN Unlock Forecast - 30 Days FREE Trial $33M 4.2x 0.4x
BANR Unlock Forecast - 30 Days FREE Trial $2305M 12.1x 1.2x
BCML Unlock Forecast - 30 Days FREE Trial $354M 15.3x 1.1x
BFST Unlock Forecast - 30 Days FREE Trial $821M 10.0x 0.9x
BHB Unlock Forecast - 30 Days FREE Trial $547M 15.1x 1.1x
BK Unlock Forecast - 30 Days FREE Trial $84302M 16.1x 1.9x
BK-PK Unlock Forecast - 30 Days FREE Trial $18297M 3.5x 0.4x
BKSC Unlock Forecast - 30 Days FREE Trial $89M 13.6x 2.1x
BMRC Unlock Forecast - 30 Days FREE Trial $443M 44.9x 1.0x
BOH Unlock Forecast - 30 Days FREE Trial $2751M 14.9x 1.5x
BOH-PA Unlock Forecast - 30 Days FREE Trial $652M 3.5x 0.4x
BOH-PB Unlock Forecast - 30 Days FREE Trial $1055M 5.7x 0.6x
BOTJ Unlock Forecast - 30 Days FREE Trial $81M 10.2x 1.1x
BPOP Unlock Forecast - 30 Days FREE Trial $8107M 10.4x 1.3x
BPOPM Unlock Forecast - 30 Days FREE Trial $1676M 2.2x 0.3x
BPOPO Unlock Forecast - 30 Days FREE Trial $1675M 2.2x 0.3x
BPRN Unlock Forecast - 30 Days FREE Trial $246M 13.8x 0.9x
BSRR Unlock Forecast - 30 Days FREE Trial $459M 11.5x 1.3x
BSVN Unlock Forecast - 30 Days FREE Trial $413M 9.5x 1.7x
BUSE Unlock Forecast - 30 Days FREE Trial $2235M 21.8x 0.9x
BUSEP Unlock Forecast - 30 Days FREE Trial $2264M 22.1x 0.9x
BWB Unlock Forecast - 30 Days FREE Trial $516M 12.6x 1.0x
BWBBP Unlock Forecast - 30 Days FREE Trial $551M 13.4x 1.1x
BWFG Unlock Forecast - 30 Days FREE Trial $385M 13.3x 1.3x
BY Unlock Forecast - 30 Days FREE Trial $1409M 11.2x 1.1x
CATY Unlock Forecast - 30 Days FREE Trial $3416M 11.2x 1.2x
CBAN Unlock Forecast - 30 Days FREE Trial $319M 11.5x 1.1x
CBFV Unlock Forecast - 30 Days FREE Trial $173M 64.1x 1.1x
CBSH Unlock Forecast - 30 Days FREE Trial $6731M 12.0x 2.7x
CCB Unlock Forecast - 30 Days FREE Trial $1724M 36.1x 3.6x
CCBG Unlock Forecast - 30 Days FREE Trial $767M 12.6x 1.4x
CCFN Unlock Forecast - 30 Days FREE Trial $191M 8.7x 1.0x
CCNE Unlock Forecast - 30 Days FREE Trial $643M 13.5x 0.8x
CCNEP Unlock Forecast - 30 Days FREE Trial $577M 12.1x 0.7x
CFFI Unlock Forecast - 30 Days FREE Trial $238M 9.1x 0.9x
CFG Unlock Forecast - 30 Days FREE Trial $25193M 14.8x 1.0x
CFG-PE Unlock Forecast - 30 Days FREE Trial $8301M 4.9x 0.3x
CFG-PH Unlock Forecast - 30 Days FREE Trial $11494M 6.8x 0.5x
CHMG Unlock Forecast - 30 Days FREE Trial $277M 20.8x 1.1x
CIVB Unlock Forecast - 30 Days FREE Trial $371M 8.5x 1.0x
CIZN Unlock Forecast - 30 Days FREE Trial $44M 126.4x 1.0x
CNOB Unlock Forecast - 30 Days FREE Trial $1390M 22.7x 0.9x
CNOBP Unlock Forecast - 30 Days FREE Trial $1214M 19.8x 0.8x
COFS Unlock Forecast - 30 Days FREE Trial $479M 22.3x 1.1x
COLB Unlock Forecast - 30 Days FREE Trial $8747M 18.3x 1.1x
COSO Unlock Forecast - 30 Days FREE Trial $269M x 1.1x
CPF Unlock Forecast - 30 Days FREE Trial $870M 13.2x 1.5x
CSBB Unlock Forecast - 30 Days FREE Trial $129M 9.3x 1.0x
CTBI Unlock Forecast - 30 Days FREE Trial $1089M 11.7x 1.3x
CUBB Unlock Forecast - 30 Days FREE Trial $743M 4.2x 0.4x
CUBI Unlock Forecast - 30 Days FREE Trial $2493M 14.1x 1.2x
CUBI-PF Unlock Forecast - 30 Days FREE Trial $853M 4.8x 0.4x
CVBF Unlock Forecast - 30 Days FREE Trial $2739M 13.4x 1.2x
CWBC Unlock Forecast - 30 Days FREE Trial $454M 13.4x 1.1x
CZFS Unlock Forecast - 30 Days FREE Trial $294M 8.6x 0.9x
CZNC Unlock Forecast - 30 Days FREE Trial $336M 12.4x 1.1x
EBMT Unlock Forecast - 30 Days FREE Trial $141M 10.4x 0.8x
EFSC Unlock Forecast - 30 Days FREE Trial $2099M 10.7x 1.1x
EFSCP Unlock Forecast - 30 Days FREE Trial $735M 3.8x 0.4x
EFSI Unlock Forecast - 30 Days FREE Trial $213M 21.2x 1.2x
EGBN Unlock Forecast - 30 Days FREE Trial $649M -22.5x 0.6x
EMYB Unlock Forecast - 30 Days FREE Trial $137M 10.7x 1.1x
EQBK Unlock Forecast - 30 Days FREE Trial $852M 48.3x 1.2x
EWBC Unlock Forecast - 30 Days FREE Trial $15803M 12.5x 1.8x
FBIZ Unlock Forecast - 30 Days FREE Trial $474M 9.2x 1.3x
FBK Unlock Forecast - 30 Days FREE Trial $3155M 30.5x 1.6x
FBNC Unlock Forecast - 30 Days FREE Trial $2213M 22.4x 1.4x
FBP Unlock Forecast - 30 Days FREE Trial $3370M 10.1x 1.8x
FCBC Unlock Forecast - 30 Days FREE Trial $642M 13.0x 1.3x
FCCO Unlock Forecast - 30 Days FREE Trial $236M 12.7x 1.5x
FCNCA Unlock Forecast - 30 Days FREE Trial $27170M 11.7x 1.2x
FCNCB Unlock Forecast - 30 Days FREE Trial $22074M 9.5x 1.0x
FCNCO Unlock Forecast - 30 Days FREE Trial $293M 0.1x 0.0x
FCNCP Unlock Forecast - 30 Days FREE Trial $286M 0.1x 0.0x
FFIC Unlock Forecast - 30 Days FREE Trial $577M 19.5x 0.8x
FFIN Unlock Forecast - 30 Days FREE Trial $4531M 18.7x 2.5x
FFWM Unlock Forecast - 30 Days FREE Trial $502M -23.9x 0.6x
FHB Unlock Forecast - 30 Days FREE Trial $3218M 12.4x 1.2x
FIBK Unlock Forecast - 30 Days FREE Trial $3680M 15.0x 1.1x
FINW Unlock Forecast - 30 Days FREE Trial $241M 16.1x 1.3x
FITB Unlock Forecast - 30 Days FREE Trial $29962M 12.4x 1.4x
FITBI Unlock Forecast - 30 Days FREE Trial $17080M 7.1x 0.8x
FITBO Unlock Forecast - 30 Days FREE Trial $12734M 5.3x 0.6x
FITBP Unlock Forecast - 30 Days FREE Trial $16334M 6.8x 0.8x
FKYS Unlock Forecast - 30 Days FREE Trial $108M 11.9x 1.0x
FMBH Unlock Forecast - 30 Days FREE Trial $1007M 11.5x 1.1x
FMBM Unlock Forecast - 30 Days FREE Trial $97M 11.4x 1.0x
FMNB Unlock Forecast - 30 Days FREE Trial $544M 10.0x 1.2x
FRAF Unlock Forecast - 30 Days FREE Trial $248M 15.8x 1.5x
FSBC Unlock Forecast - 30 Days FREE Trial $796M 13.9x 1.9x
FUSB Unlock Forecast - 30 Days FREE Trial $81M 14.5x 1.0x
FVCB Unlock Forecast - 30 Days FREE Trial $248M 11.6x 1.0x
FXNC Unlock Forecast - 30 Days FREE Trial $233M 20.7x 1.3x
GABC Unlock Forecast - 30 Days FREE Trial $1534M 15.3x 1.4x
GBCI Unlock Forecast - 30 Days FREE Trial $5215M 22.0x 1.5x
GBFH Unlock Forecast - 30 Days FREE Trial $543M 40.1x 3.4x
GLBZ Unlock Forecast - 30 Days FREE Trial $12M 188.1x 0.6x
GSBC Unlock Forecast - 30 Days FREE Trial $736M 10.6x 1.2x
HBIA Unlock Forecast - 30 Days FREE Trial $699M 12.3x 1.3x
HBNC Unlock Forecast - 30 Days FREE Trial $831M 13.5x 1.3x
HBT Unlock Forecast - 30 Days FREE Trial $836M 10.7x 1.4x
HNVR Unlock Forecast - 30 Days FREE Trial $166M 14.6x 0.8x
HOMB Unlock Forecast - 30 Days FREE Trial $5657M 15.8x 1.3x
HONE Unlock Forecast - 30 Days FREE Trial $521M 19.8x 0.9x
HTBK Unlock Forecast - 30 Days FREE Trial $738M 17.0x 1.1x
HTH Unlock Forecast - 30 Days FREE Trial $2143M 13.4x 1.0x
HWC Unlock Forecast - 30 Days FREE Trial $5559M 13.1x 1.2x
HWCPZ Unlock Forecast - 30 Days FREE Trial $1981M 5.5x 0.4x
IBCP Unlock Forecast - 30 Days FREE Trial $721M 10.5x 1.5x
IBOC Unlock Forecast - 30 Days FREE Trial $4514M 10.7x 1.4x
INBK Unlock Forecast - 30 Days FREE Trial $172M 11.3x 0.5x
INBKZ Unlock Forecast - 30 Days FREE Trial $215M 13.9x 0.6x
INDB Unlock Forecast - 30 Days FREE Trial $3818M 21.2x 1.1x
ISBA Unlock Forecast - 30 Days FREE Trial $363M 19.9x 1.6x
ISTR Unlock Forecast - 30 Days FREE Trial $267M 11.6x 0.9x
JMSB Unlock Forecast - 30 Days FREE Trial $295M 14.7x 1.1x
LKFN Unlock Forecast - 30 Days FREE Trial $1522M 15.6x 2.0x
LNKB Unlock Forecast - 30 Days FREE Trial $309M 8.1x 1.1x
LOB Unlock Forecast - 30 Days FREE Trial $1428M 27.9x 1.3x
MBCN Unlock Forecast - 30 Days FREE Trial $298M 14.1x 1.3x
MBIN Unlock Forecast - 30 Days FREE Trial $1663M 6.7x 0.8x
MBINL Unlock Forecast - 30 Days FREE Trial $1064M 4.3x 0.5x
MBINM Unlock Forecast - 30 Days FREE Trial $1145M 4.6x 0.5x
MBINN Unlock Forecast - 30 Days FREE Trial $873M 3.5x 0.4x
MBWM Unlock Forecast - 30 Days FREE Trial $806M 9.4x 1.2x
MCB Unlock Forecast - 30 Days FREE Trial $830M 13.0x 1.1x
MCBS Unlock Forecast - 30 Days FREE Trial $733M 11.0x 1.6x
MNSB Unlock Forecast - 30 Days FREE Trial $153M 11.1x 0.7x
MNSBP Unlock Forecast - 30 Days FREE Trial $191M 13.3x 0.9x
MOFG Unlock Forecast - 30 Days FREE Trial $849M 14.5x 1.4x
MPB Unlock Forecast - 30 Days FREE Trial $739M 14.8x 0.9x
MSBI Unlock Forecast - 30 Days FREE Trial $459M 7.4x 0.8x
MSBIP Unlock Forecast - 30 Days FREE Trial $535M 9.7x 0.9x
MTB Unlock Forecast - 30 Days FREE Trial $32717M 11.8x 1.1x
MTB-PH Unlock Forecast - 30 Days FREE Trial $3976M 1.4x 0.1x
MTB-PJ Unlock Forecast - 30 Days FREE Trial $4236M 1.5x 0.2x
MVBF Unlock Forecast - 30 Days FREE Trial $347M 10.8x 1.1x
MYFW Unlock Forecast - 30 Days FREE Trial $249M 19.8x 1.0x
NPB Unlock Forecast - 30 Days FREE Trial $599M 10.0x 1.0x
NTRS Unlock Forecast - 30 Days FREE Trial $26197M 15.2x 2.0x
NTRSO Unlock Forecast - 30 Days FREE Trial $3684M 2.1x 0.3x
NWFL Unlock Forecast - 30 Days FREE Trial $275M 35.8x 1.2x
NWPP Unlock Forecast - 30 Days FREE Trial $90M 9.2x 1.1x
OBK Unlock Forecast - 30 Days FREE Trial $1226M 20.5x 1.0x
OBT Unlock Forecast - 30 Days FREE Trial $387M 10.6x 1.4x
OFG Unlock Forecast - 30 Days FREE Trial $1868M 9.4x 1.4x
OPBK Unlock Forecast - 30 Days FREE Trial $220M 9.3x 1.0x
ORRF Unlock Forecast - 30 Days FREE Trial $738M 10.1x 1.3x
OSBC Unlock Forecast - 30 Days FREE Trial $1080M 15.3x 1.3x
OVBC Unlock Forecast - 30 Days FREE Trial $198M 14.0x 1.4x
OVLY Unlock Forecast - 30 Days FREE Trial $254M 10.8x 1.3x
PB Unlock Forecast - 30 Days FREE Trial $6918M 13.0x 0.9x
PBHC Unlock Forecast - 30 Days FREE Trial $67M 8.8x 0.6x
PCB Unlock Forecast - 30 Days FREE Trial $331M 9.4x 0.9x
PEBK Unlock Forecast - 30 Days FREE Trial $186M 11.1x 1.3x
PEBO Unlock Forecast - 30 Days FREE Trial $1110M 10.9x 0.9x
PFBX Unlock Forecast - 30 Days FREE Trial $94M 19.8x 0.9x
PKBK Unlock Forecast - 30 Days FREE Trial $302M 8.9x 1.0x
PMHG Unlock Forecast - 30 Days FREE Trial $180M 22.2x 2.0x
QCRH Unlock Forecast - 30 Days FREE Trial $1458M 12.0x 1.3x
QNBC Unlock Forecast - 30 Days FREE Trial $132M 10.0x 1.1x
RBB Unlock Forecast - 30 Days FREE Trial $375M 14.4x 0.7x
RBCAA Unlock Forecast - 30 Days FREE Trial $1471M 11.5x 1.4x
RMBI Unlock Forecast - 30 Days FREE Trial $141M 13.3x 1.0x
RNST Unlock Forecast - 30 Days FREE Trial $3527M 24.0x 0.9x
RRBI Unlock Forecast - 30 Days FREE Trial $487M 12.0x 1.4x
RVRF Unlock Forecast - 30 Days FREE Trial $294M 7.3x 1.1x
SBCF Unlock Forecast - 30 Days FREE Trial $2861M 19.8x 1.2x
SBFG Unlock Forecast - 30 Days FREE Trial $136M 10.0x 1.0x
SBSI Unlock Forecast - 30 Days FREE Trial $970M 13.9x 1.2x
SFBS Unlock Forecast - 30 Days FREE Trial $4067M 15.9x 2.3x
SFDL Unlock Forecast - 30 Days FREE Trial $99M 7.7x 0.5x
SLBK Unlock Forecast - 30 Days FREE Trial $103M 7.4x 1.0x
SPFI Unlock Forecast - 30 Days FREE Trial $669M 11.2x 1.4x
SRCE Unlock Forecast - 30 Days FREE Trial $1614M 10.9x 1.3x
SSB Unlock Forecast - 30 Days FREE Trial $9713M 14.0x 1.1x
STBA Unlock Forecast - 30 Days FREE Trial $1618M 12.1x 1.1x
STT Unlock Forecast - 30 Days FREE Trial $36031M 12.1x 1.3x
STT-PG Unlock Forecast - 30 Days FREE Trial $6212M 2.1x 0.2x
SYBT Unlock Forecast - 30 Days FREE Trial $2039M 15.1x 2.0x
TCBI Unlock Forecast - 30 Days FREE Trial $4423M 14.7x 1.2x
TCBIO Unlock Forecast - 30 Days FREE Trial $963M 3.2x 0.3x
TCBK Unlock Forecast - 30 Days FREE Trial $1604M 13.7x 1.2x
TECTP Unlock Forecast - 30 Days FREE Trial $75M 4.3x 0.6x
TFIN Unlock Forecast - 30 Days FREE Trial $1447M 145.0x 1.6x
THFF Unlock Forecast - 30 Days FREE Trial $760M 13.2x 1.2x
TMP Unlock Forecast - 30 Days FREE Trial $1062M 12.6x 1.5x
TRST Unlock Forecast - 30 Days FREE Trial $823M 14.5x 1.2x
TYFG Unlock Forecast - 30 Days FREE Trial $116M x 0.8x
UBCP Unlock Forecast - 30 Days FREE Trial $77M 10.2x 1.2x
UBSI Unlock Forecast - 30 Days FREE Trial $5572M 13.0x 1.0x
UCB Unlock Forecast - 30 Days FREE Trial $3937M 12.4x 1.1x
UCB-PI Unlock Forecast - 30 Days FREE Trial $3035M 11.1x 0.8x
UNTY Unlock Forecast - 30 Days FREE Trial $552M 10.2x 1.7x
UVSP Unlock Forecast - 30 Days FREE Trial $997M 11.5x 1.1x
UWHR Unlock Forecast - 30 Days FREE Trial $73M 7.4x 1.2x
VBTX Unlock Forecast - 30 Days FREE Trial $3308M 28.6x 2.0x
WAL Unlock Forecast - 30 Days FREE Trial $9600M 10.7x 1.3x
WAL-PA Unlock Forecast - 30 Days FREE Trial $2469M 2.7x 0.3x
WASH Unlock Forecast - 30 Days FREE Trial $586M 13.8x 1.1x
WTBA Unlock Forecast - 30 Days FREE Trial $396M 12.3x 1.6x
WTFC Unlock Forecast - 30 Days FREE Trial $9555M 12.2x 1.4x
WTFCN Unlock Forecast - 30 Days FREE Trial $1788M 2.3x 0.3x

Frequently Asked Questions - Midland States Bancorp, Inc. Stock Forecast

How accurate are Midland States Bancorp, Inc. stock predictions?

Our AI model shows a 6% Spearman correlation coefficient for MSBI predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Midland States Bancorp, Inc. stock price forecasts?

Our analysis considers Midland States Bancorp, Inc.'s financial metrics, Finance sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Midland States Bancorp, Inc. a good investment in 2025?

Based on our AI analysis, Midland States Bancorp, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Midland States Bancorp, Inc. forecasts updated?

Midland States Bancorp, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Midland States Bancorp, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Midland States Bancorp, Inc. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...